Unmet needs in appendiceal neuroendocrine neoplasms Review


Authors: Toumpanakis, C.; Fazio, N.; Janson, E. T.; Horsch, D.; Pascher, A.; Reed, N.; O'Toole, D.; van Dijkum, E. N.; Partelli, S.; Rinke, A.; Kos-Kudla, B.; Costa, F.; Pape, U. F.; Grozinsky-Glasberg, S.; Scoazec, J. Y.; The ENETS 2016 Munich Advisory Board Participants
Contributor: Bodei, L.
Review Title: Unmet needs in appendiceal neuroendocrine neoplasms
Abstract: Appendiceal neuroendocrine neoplasms (ANEN) are mostly discovered coincidentally during appendicectomy and usually have a benign clinical course; thus, appendicectomy alone is considered curative. However, in some cases, a malignant potential is suspected, and therefore additional operations such as completion right hemicolectomy are considered. The existing European Neuroendocrine Tumour Society (ENETS) guidelines provide useful data about epidemiology and prognosis, as well as practical recommendations with regards to the risk factors for a more aggressive disease course and the indications for a secondary operation. However, these guidelines are based on heterogeneous and retrospective studies. Therefore, the evidence does not seem to be robust, and there are still unmet needs in terms of accurate epidemiology and overall prognosis, optimal diagnostic and follow-up strategy, as well as identified risk factors that would indicate a more aggressive surgical approach at the beginning and a more intense follow-up. In this review, we are adopting a critical approach of the ENETS guidelines and published series for ANEN, focusing on the above-noted grey areas.
Keywords: survival; classification; netherlands; appendix; epidemiology; carcinoid-tumors; decades; enets consensus guidelines; right hemicolectomy; carcinoids; appendiceal neuroendocrine neoplasms; appendicectomy
Journal Title: Neuroendocrinology
Volume: 108
Issue: 1
ISSN: 0028-3835
Publisher: S. Karger AG  
Date Published: 2019-01-01
Start Page: 37
End Page: 44
Language: English
ACCESSION: WOS:000456048400005
DOI: 10.1159/000493894
PROVIDER: wos
PUBMED: 30235454
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa   Bodei
    210 Bodei